Cancer Causes & Control

, Volume 23, Issue 1, pp 23–33 | Cite as

Associations of whole-blood fatty acids and dietary intakes with prostate cancer in Jamaica

  • Maria D. Jackson
  • Susan P. Walker
  • Candace M. Simpson-Smith
  • Carole M. Lindsay
  • Garret Smith
  • Norma McFarlane-Anderson
  • Franklyn I. Bennett
  • Kathleen C. M. Coard
  • William D. Aiken
  • Trevor Tulloch
  • Tomlin J. Paul
  • Robert L. Wan
Original paper



To investigate the association of whole-blood fatty acids and reported intakes of fats with risk of prostate cancer (PCa).


Case–control study of 209 men 40–80 years old with newly diagnosed, histologically confirmed prostate cancer and 226 cancer-free men attending the same urology clinics. Whole-blood fatty acid composition (mol%) was measured by gas chromatography and diet assessed by food frequency questionnaire.


High whole-blood oleic acid composition (tertile 3 vs. tertile 1: OR, 0.37; CI, 0.14–0.0.98) and moderate palmitic acid proportions (tertile 2: OR, 0.29; CI, 0.12–0.70) (tertile 3: OR, 0.53; CI, 0.19–1.54) were inversely related to risk of PCa, whereas men with high linolenic acid proportions were at increased likelihood of PCa (tertile 3 vs. tertile 1: OR, 2.06; 1.29–3.27). Blood myristic, stearic and palmitoleic acids were not associated with PCa. Higher intakes of dietary MUFA were inversely related to prostate cancer (tertile 3 vs. tertile 1: OR, 0.39; CI 0.16–0.92). The principal source of dietary MUFA was avocado intake. Dietary intakes of other fats were not associated with PCa.


Whole-blood and dietary MUFA reduced the risk of prostate cancer. The association may be related to avocado intakes. High blood linolenic acid was directly related to prostate cancer. These associations warrant further investigation.


Prostate cancer Whole-blood fatty acids Dietary fat intake Avocado intake 



This study was supported by the National Health Fund and the Planning Institute of Jamaica and University of the West Indies. The authors wish to thank the research nurses—Barbara Panton, Elsa Brown, Nicola Meeks-Aitken, Donnahae Rhoden-Salmon—and study participants for their support in the investigation.

Conflict of interest

None of the authors had a conflict of interest to disclose.


  1. 1.
    Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRefGoogle Scholar
  2. 2.
    Stamatiou K, Delakas D, Sofras F (2007) Mediterranean diet, monounsaturated: saturated fat ratio and low prostate cancer risk. A myth or a reality? Minerva Urol Nefrol 59:59–66PubMedGoogle Scholar
  3. 3.
    Chan JM, Gann PH, Giovannucci EL (2005) Role of diet in prostate cancer development and progression. J Clin Oncol 23:8152–8160PubMedCrossRefGoogle Scholar
  4. 4.
    Gibson TN, Hanchard B, Waugh N, McNaughton D (2010) Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 2003–2007. West Indian Med J 59:456–464PubMedGoogle Scholar
  5. 5.
    Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7–33PubMedCrossRefGoogle Scholar
  6. 6.
    Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRefGoogle Scholar
  7. 7.
    Anonymous (1997) Cancer incidence in five continents, vol VII. IARC Sci Publ, pp i–1240Google Scholar
  8. 8.
    Institute of Medicine (2005) Dietary reference intakes for energy, carbohydrate, fibre, fat, fatty acids, cholesterol, protein and amino acids. National Academies Press, Washington, DCGoogle Scholar
  9. 9.
    Kolonel LN, Hankin JH, Lee J, Chu SY, Nomura AM, Hinds MW (1981) Nutrient intakes in relation to cancer incidence in Hawaii. Br J Cancer 44:332–339PubMedCrossRefGoogle Scholar
  10. 10.
    Hursting SD, Thornquist M, Henderson MM (1990) Types of dietary fat and the incidence of cancer at five sites. Prev Med 19:242–253PubMedCrossRefGoogle Scholar
  11. 11.
    World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. Second expert report: a global perspective. AICR, Washington, DC (Ref type: report)Google Scholar
  12. 12.
    Bingham SA (2002) Biomarkers in nutritional epidemiology. Public Health Nutr 5:821–827PubMedCrossRefGoogle Scholar
  13. 13.
    Arab L, Akbar J (2002) Biomarkers and the measurement of fatty acids. Public Health Nutr 5:865–871PubMedCrossRefGoogle Scholar
  14. 14.
    Willett WC (1990) Nutritional epidemiology. Oxford University Press, New YorkGoogle Scholar
  15. 15.
    Gleason DF, Mellinger GT (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58–64PubMedGoogle Scholar
  16. 16.
    Jackson M, Walker S, Cade J, Forrester T, Cruickshank JK, Wilks R (2001) Reproducibility and validity of a quantitative food-frequency questionnaire among Jamaicans of African origin. Public Health Nutr 4:971–980PubMedGoogle Scholar
  17. 17.
    Jackson MD, Walker SP, Younger NM, Bennett FI (2011) Use of a food frequency questionnaire to assess diets of Jamaican adults: validation and correlation with biomarkers. Nutr J 10:28PubMedCrossRefGoogle Scholar
  18. 18.
    Zock PL, Mensink RP, Harryvan J, de Vries JH, Katan MB (1997) Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. Am J Epidemiol 145:1114–1122PubMedGoogle Scholar
  19. 19.
    Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L (1997) Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 71:545–551PubMedCrossRefGoogle Scholar
  20. 20.
    Mannisto S, Pietinen P, Virtanen MJ et al (2003) Fatty acids and risk of prostate cancer in a nested case–control study in male smokers. Cancer Epidemiol Biomarkers Prev 12:1422–1428PubMedGoogle Scholar
  21. 21.
    Crowe FL, Allen NE, Appleby PN et al (2008) Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case–control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88:1353–1363PubMedGoogle Scholar
  22. 22.
    Park SY, Wilkens LR, Henning SM et al (2009) Circulating fatty acids and prostate cancer risk in a nested case–control study: the Multiethnic Cohort. Cancer Causes Control 20:211–223PubMedCrossRefGoogle Scholar
  23. 23.
    Lu QY, Arteaga JR, Zhang Q, Huerta S, Go VL, Heber D (2005) Inhibition of prostate cancer cell growth by an avocado extract: role of lipid-soluble bioactive substances. J Nutr Biochem 16:23–30PubMedCrossRefGoogle Scholar
  24. 24.
    Takenaga F, Matsuyama K, Abe S, Torii Y, Itoh S (2008) Lipid and fatty acid composition of mesocarp and seed of avocado fruits harvested at northern range in Japan. J Oleo Sci 57:591–597PubMedCrossRefGoogle Scholar
  25. 25.
    Ding H, Chin YW, Kinghorn AD, D’Ambrosio SM (2007) Chemopreventive characteristics of avocado fruit. Semin Cancer Biol 17:386–394PubMedCrossRefGoogle Scholar
  26. 26.
    Bidoli E, Talamini R, Bosetti C et al (2005) Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol 16:152–157PubMedCrossRefGoogle Scholar
  27. 27.
    Giovannucci E, Rimm EB, Colditz GA et al (1993) A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85:1571–1579PubMedCrossRefGoogle Scholar
  28. 28.
    Kristal AR, Cohen JH, Qu P, Stanford JL (2002) Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11:719–725PubMedGoogle Scholar
  29. 29.
    West DW, Slattery ML, Robison LM, French TK, Mahoney AW (1991) Adult dietary intake and prostate cancer risk in Utah: a case–control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85–94PubMedCrossRefGoogle Scholar
  30. 30.
    Neuhouser ML, Barnett MJ, Kristal AR et al (2007) (n-6) PUFA increase and dairy foods decrease prostate cancer risk in heavy smokers. J Nutr 137:1821–1827PubMedGoogle Scholar
  31. 31.
    Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN (2007) Fat and meat intake and prostate cancer risk: the multiethnic cohort study. Int J Cancer 121:1339–1345PubMedCrossRefGoogle Scholar
  32. 32.
    Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E (2007) A prospective study on dietary fat and incidence of prostate cancer (Malmo, Sweden). Cancer Causes Control 18:1107–1121PubMedCrossRefGoogle Scholar
  33. 33.
    Schuurman AG, van den Brandt PA, Dorant E, Brants HA, Goldbohm RA (1999) Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study. Cancer 86:1019–1027PubMedCrossRefGoogle Scholar
  34. 34.
    Whittemore AS, Kolonel LN, Wu AH et al (1995) Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87:652–661PubMedCrossRefGoogle Scholar
  35. 35.
    Crowe FL, Key TJ, Appleby PN et al (2008) Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 87:1405–1413PubMedGoogle Scholar
  36. 36.
    Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM (2000) Men who consume vegetable oils rich in monounsaturated fat: their dietary patterns and risk of prostate cancer (New Zealand). Cancer Causes Control 11:609–615PubMedCrossRefGoogle Scholar
  37. 37.
    Escrich E, Moral R, Grau L, Costa I, Solanas M (2007) Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol Nutr Food Res 51:1279–1292PubMedGoogle Scholar
  38. 38.
    Waterman E, Lockwood B (2007) Active components and clinical applications of olive oil. Altern Med Rev 12:331–342PubMedGoogle Scholar
  39. 39.
    Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ (1994) Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86:281–286PubMedCrossRefGoogle Scholar
  40. 40.
    Wakil SJ, Stoops JK, Joshi VC (1983) Fatty acid synthesis and its regulation. Annu Rev Biochem 52:537–579PubMedCrossRefGoogle Scholar
  41. 41.
    Wakil SJ (1989) Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28:4523–4530PubMedCrossRefGoogle Scholar
  42. 42.
    Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J (2007) A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16:1364–1370PubMedCrossRefGoogle Scholar
  43. 43.
    Laaksonen DE, Laukkanen JA, Niskanen L et al (2004) Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: a population-based cohort study. Int J Cancer 111:444–450PubMedCrossRefGoogle Scholar
  44. 44.
    Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65:1097–1098PubMedCrossRefGoogle Scholar
  45. 45.
    Brasky TM, Till C, White E et al (2011) Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 173:1429–1439PubMedCrossRefGoogle Scholar
  46. 46.
    Chavarro JE, Stampfer MJ, Campos H, Kurth T, Willett WC, Ma J (2008) A prospective study of trans-fatty acid levels in blood and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 17:95–101PubMedCrossRefGoogle Scholar
  47. 47.
    Simon JA, Chen YH, Bent S (2009) The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis. Am J Clin Nutr 89:1558S–1564SPubMedCrossRefGoogle Scholar
  48. 48.
    Connolly JM, Coleman M, Rose DP (1997) Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer 29:114–119PubMedCrossRefGoogle Scholar
  49. 49.
    Rose DP (1997) Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr 66:1513S–1522SPubMedGoogle Scholar
  50. 50.
    Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD (1995) Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87:1456–1462PubMedCrossRefGoogle Scholar
  51. 51.
    Godley PA, Campbell MK, Gallagher P, Martinson FE, Mohler JL, Sandler RS (1996) Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 5:889–895PubMedGoogle Scholar
  52. 52.
    Newcomer LM, King IB, Wicklund KG, Stanford JL (2001) The association of fatty acids with prostate cancer risk. Prostate 47:262–268PubMedCrossRefGoogle Scholar
  53. 53.
    Hedelin M, Chang ET, Wiklund F et al (2007) Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer 120:398–405PubMedCrossRefGoogle Scholar
  54. 54.
    Polascik TJ, Oesterling JE, Partin AW (1999) Prostate specific antigen: a decade of discovery—what we have learned and where we are going. J Urol 162:293–306PubMedCrossRefGoogle Scholar
  55. 55.
    Thompson IM, Pauler DK, Goodman PJ et al (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 350:2239–2246PubMedCrossRefGoogle Scholar
  56. 56.
    Ando R, Nagaya T, Hashimoto Y et al (2008) Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a hospital-based cross-sectional survey, 2004–2006. Urology 72:561–565PubMedCrossRefGoogle Scholar
  57. 57.
    Baillargeon J, Pollock BH, Kristal AR et al (2005) The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103:1092–1095PubMedCrossRefGoogle Scholar
  58. 58.
    Beebe-Dimmer JL, Faerber GJ, Morgenstern H et al (2008) Body composition and serum prostate-specific antigen: review and findings from Flint Men’s Health Study. Urology 71:554–560PubMedCrossRefGoogle Scholar
  59. 59.
    Werny DM, Thompson T, Saraiya M et al (2007) Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001–2004. Cancer Epidemiol Biomarkers Prev 16:70–76PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Maria D. Jackson
    • 1
  • Susan P. Walker
    • 2
  • Candace M. Simpson-Smith
    • 2
  • Carole M. Lindsay
    • 3
  • Garret Smith
    • 3
  • Norma McFarlane-Anderson
    • 3
  • Franklyn I. Bennett
    • 4
  • Kathleen C. M. Coard
    • 4
  • William D. Aiken
    • 5
  • Trevor Tulloch
    • 5
  • Tomlin J. Paul
    • 1
  • Robert L. Wan
    • 6
  1. 1.Department of Community Health and PsychiatryUniversity of the West IndiesMona, KingstonJamaica
  2. 2.Tropical Medicine Research InstituteUniversity of the West IndiesMona, KingstonJamaica
  3. 3.Department of Basic Medical SciencesUniversity of the West IndiesMona, KingstonJamaica
  4. 4.Department of PathologyUniversity of the West IndiesMona, KingstonJamaica
  5. 5.Department of Surgery, Radiology, Anaesthesia, and Intensive CareUniversity of the West IndiesMona, KingstonJamaica
  6. 6.Kingston Public HospitalKingstonJamaica

Personalised recommendations